Board of Directors

Board of Directors

Ted Moroz

Ted Moroz

Chair of the Board

Ted Moroz has been President of The Beer Store and Brewers' Distributor Limited since September, 2009. In this role he oversees 450 Retail Stores in Ontario, 16 Distribution Centres from British Columbia to Ottawa, and multiple cross-dock facilities throughout Canada, with a total of 7,000+ employees. Ted started his career with The Beer Store (then Brewers Retail Inc.) in 1989, holding various management positions over the years. The Beer Store has been a proud partner of United Food & Commercial Workers (UFCW) Local 12R24 in organizing an annual Returns For Leukemia Bottle Drive since 2006. Ted joined the LLSC National Board in 2010. 

Scott Carroll

Scott Carroll

Vice Chair

Scott A. Carroll is the resident manager of the Cincinnati, Ohio office of Jackson Lewis LLP.  Scott has represented clients across the spectrum of labor and employment law, including wrongful discharge litigation, collective bargaining,union avoidance, and human resources counseling.  He has expertise in drafting,counseling, prosecuting, and defending theft of trade secret cases and/or non-compete, non-solicitation cases.  Scott is a member of the U.S. Sixth Circuit Bar Association, the Federal Bar Association, the Ohio State Bar Association, and the Cincinnati Bar Association.  He received his B.S. degree from the University of Cincinnati in 1990, and he earned his J.D. from the University of Cincinnati -College of Law in 1993, where he was a member of the University of Cincinnati Law Review.   Scott became a member of the South Ohio chapter in 2002 and was chapter president in 2005.  

Dr. Keith Humphries

Dr. Keith Humphries

Secretary & Chair of Medical & Scientific Committee

Dr. Keith Humphries, MD PhD, is a distinguished scientist and Director of the Terry Fox Laboratory of the BC Cancer Agency and Professor in the Division of Hematology of the Department of Medicine at the University of British Columbia. His long-standing research interests are focused on understanding the molecular mechanisms that regulate normal blood stem cell properties and how these are altered in leukemia. Studies in his lab have involved a stellar succession of trainees from Canada and around the world that have stimulated new approaches for expanding normal blood stem cells and provided new insights into the mechanisms of leukemic transformation. His laboratory has also been on the forefront of the use of retroviral and lentiviral - mediated gene transfer to human as well as mouse blood stem cells and has used this technology to develop powerful new models for studying how specific genes contribute to leukemia development. He is an active promoter of translational science and a collaborator on many team projects both nationally and internationally. He has a long track record of research accomplishments supported and contributions to scientific societies and journals. Dr. Humphries has been recognized by numerous prestigious awards including the 2013 Terry Fox Gold Medal and induction as a Fellow of the Royal Society of Canada.

He has been an active member of many international scientific societies. He has served in senior elected executive roles in the International Society of Experimental Hematology, and served as President and then as Editor in Chief of the associations journal, Experimental Hematology. He was a founding member in 1999 of the NCE-funded Stem Cell Network and remains active in the Canadian Stem Cell Network Foundation. He currently serves on the Scientific Advisory Board of the Hemato-Linne Stem Cell Program (centered in Lund, Sweden) and bluebird bio and has previously been an advisor to the hematology research program at Millenium and Systemix. He has previously served as an advisor to the Terry Fox Foundation and currently sits on the Medical-Scientific committee of the Leukemia Lymphoma Society of Canada.  Dr. Humphries has served on numerous review panels both nationally and internationally including serving as member of the Score Committee of the Leukemia and Lymphoma Society (USA), member and chair of the scientific panel for the Leukemia Lymphoma Society of Canada, the hematopoiesis panel of the National Cancer Institute and site visit panels for the Terry Fox Program.

Jeffrey Bacha

Jeffrey Bacha

Director

Jeffrey Bacha is an experienced senior executive with more than twenty years in the life sciences industry focused in the areas of operations, strategy and finance. His background includes successful public and private company building from both a start-up and turn around perspective; establishing and leading thriving management and technical teams; and raising capital in both the public and private markets.

Currently, Jeffrey is the CEO of Edison Oncology Holding Corp., a company he established to develop and commercialize new therapies in the fight against cancer. Prior to founding Edison Oncology, he led the growth of DelMar Pharmaceuticals, Inc. from its inception in 2010 through its listing on NASDAQ and advancement of its lead product candidate to pivotal Phase 3 clinical trials. In addition to his role at Edison Oncology, Jeffrey serves as an independent director and chair of the Compensation Committee for Sernova Corp., where he has been a member of the Board of Directors since 2008. 

Jeffrey has been recognized as a “Top 40 under 40” executive by Business in Vancouver magazine and is the former Chair of the Greater Vancouver Economic Council. 

Jeffrey is active in his community through volunteerism with the Leukemia & Lymphoma Society’s Team in Training program and as former Chairman of the Board for Covenant House Vancouver.

William G. Behnke

William G. Behnke

Director

Bill Behnke is the founder and president of The Behnke Group, founded in 2005.  He is a senior executive with extensive background in direct sales, marketing, sales management, and business development, with a specialization in the health care market.  He has more than 15 years of experience selling to CEOs, CFOs, CMOs and board of directors of health insurance companies and hospitals, and has significant success raising capital from venture capital firms, private equity firms, and accredited private investors.  Mr. Behnke has been instrumental in opening doors; most recently he has recruited and supported the last two Men of the Year candidates in the United States.

Alex Beraskow

Alex Beraskow

Director

Alex Beraskow is a retired management consultant with strong expertise in finance and information technology.  He started his career with IBM in 1969 and has worked within the IT domain since. He has had executive responsibility for 5 consulting firms since 1980 and also founded three consulting companies and sold each of them to international firms.

Currently, he is working as a corporate director for both Not-For-Profit (NFP), as well as corporate boards.  He is a former board member of Lymphoma Canada, Ottawa Singers, Opera Lyra, Rideau Club and the Rideau Tennis and Squash Club. 

Alex has an engineering degree from McGill University and MBA Degrees from McGill University and Ottawa University. He has also completed the ICD (Institute of Corporate Directors) program,

In 2013, he completed the Tour D’Afrique (a 12,000 km cycling trip from Cairo to Cape Town over a 4 month period), the Lands’ End to John O’Groats in 2014 (a 1,500 km trip across the UK), and a 3,000 km trip across New Zealand in 2016. 

Frédéric Chevalier

Frédéric Chevalier

Director

Frédéric is an expert in business intelligence and knowledge management. He has developed and supported several innovative and pioneering research projects in artificial intelligence and economic data management. Committed to the development of companies and organizations he works with, Frédéric uses a rigorous project management methodology and a Glow to Grow approach which allow him to contribute to the success of complex projects involving private companies and public agencies.

Frédéric was the managing partner of a consulting practice specialized in business intelligence and economic and industrial development for 14 years before he joined the Quebec Cluster of Metal Transformers as Chief Executive Officer.

As a speaker and strategic advisor, Frédéric wrote several industry reports and briefs, participated in parliamentary committees, and organized strategic forums for the development of industry clusters.

In early 2017 Frederic was diagnosed with an aggressive non-Hodgkin's lymphoma stage IV and, thanks to the support of the Canadian medical community, he is now undergoing his maintenance treatment.

 

Dan Coyle

Dan Coyle

Director

Dan Coyle is the Vice President and Eastern Region Manager for Marsh Canada’s Consumer & Commercial Department. Dan is accountable for all aspects of brokering and supporting strategies to position Marsh Canada for accelerated profitable growth in the Eastern Region, while insuring an exceptional customer experience and efficient business interactions with Marsh’s insurers and vendors. He is recognized as an inspirational leader with a high level of enthusiasm and professionalism to take on any challenge. Dan was recently recognized as one of the 2016 Young Guns of insurance by Insurance Business Magazine and Nouveaux leadeurs en assurance 2018 by Le Journal de l’Assurance.

In 2017, Dan’s uncle passed away from AML leaving his wife and two teenage daughters behind. He is actively involved in several community service organizations. Currently, he is the proud member of Montreal’s Light the Night Walk Volunteer Leadership Committee where he was Chair of the Walk in 2016. Dan and his wife are proud to raise two amazing daughters together.

Paul Davis

Paul Davis

Director

A graduate of Holland College, Paul held several posts serving the Royal Newfoundland Constabulary until his retirement from the force in 2010. His time in politics began at the municipal level in 2001, serving as councillor and deputy mayor in his home town of Conception Bay South. In 2010, Paul was elected in a by-election as the Member of the House of Assembly for the District of Topsail. In 2011, he was elevated to cabinet and served as minister in a number of portfolios including Service NL, Transportation and Works, Housing, Health and Community Services, and Child, Youth and Family Services.

From September 2014 to December 2015, Paul served as the 12th Premier of Newfoundland and Labrador then served the people of Newfoundland and Labrador as the Leader of the Official Opposition until May 2018.

Paul has been widely recognized for his public service, being named the Crime Stoppers Police Officer of the Year and the Conception Bay South Citizen of the Year. He is a recipient of the Canada 125 Medal, Queen’s Jubilee Medal and Police Exemplary Service Medal.

A devoted family man, Paul resides in the Topsail- Paradise District with his wife Cheryl.  In 2011, Paul was diagnosed with DLBC lymphoma with an underlying FL.

Louis J. DeGennaro

Louis J. DeGennaro

Director


Louis J. DeGennaro, Ph.D., was named president and chief executive officer of The Leukemia & Lymphoma Society (LLS) in September 2014 and now leads the operations of this $300 million cancer patient advocacy agency with headquarters in White Plains, New York.

A critical member of the LLS executive leadership team, he joined LLS in 2005 and was named chief mission officer in 2009, with responsibility for leadership of LLS’s mission functions of research, patient access, education, public policy and advocacy. Dr. DeGennaro is recognized as the key architect of LLS’s cures and access agenda to help save lives of blood cancer patients as well as the LLS Therapy Acceleration Program® - a venture philanthropy endeavor that defined the role of nonprofit organizations in supporting drug discovery and development with the biotechnology industry.

Dr. DeGennaro has more than 25 years of research, drug development and executive management experience in academic and private sector settings. He received his Ph.D. in biochemistry from the University of California at San Francisco and did his post-doctoral research at the Yale University School of Medicine. His previous academic appointments include research group leader, Max Planck Institute in Munich, Germany and associate professor of neurology and cell biology, University of Massachusetts Medical School. Dr. DeGennaro's private-sector positions include senior director of molecular genetics at Wyeth Pharmaceuticals, Princeton, NJ, and executive vice president for research and development, SynX Pharma, Inc. in Toronto, Canada.

Daniel DuFour

Daniel DuFour

Director

Daniel DuFour is a dynamic, innovative and highly motivated senior executive certified as a Master Black Belt in Six Sigma methodology, and experienced at leading corporate cultural transformations to streamline operations and enhance efficiency. Experienced in bringing operations into compliance with applicable regulations, monitoring performance metrics and improving productivity.

He is the Vice President - Continuous Improvement for the Canadian Dairy Division at Saputo since September 2017.  In this role, his responsibilities are to develop the Continuous Improvement (CI) strategy, lead the implementation within the Canadian division, create a CI culture and lead the change management required to create exceptional employee engagement.  Prior to Saputo, he held several senior roles with General Electric for over 16 years in Operations, Risk Management, Compliance & Governance, Continuous Improvement and Sales.

This cause is very personal for Dan because his girlfriend was diagnosed with Non-Hodgkin’s lymphoma stage IV in 2011 and has gone through chemotherapy and maintenance treatments for 3 years.  

Anna Giagkou

Anna Giagkou

Director

Anna Giagkou is a senior finance executive with over 15 years of experience in developing strategies, leading teams and driving results in the audience measurement, market research and software development industries.  In her current role as Vice President of Finance for Numeris, (an industry owned, not-for profit organization), she has extensive experience working with the Board of Directors and with the Audit Committee of the organization.  In addition to her passion for finance and media, Anna has served on a not-for-profit board supporting a community day care for six years, three of which were in the role of Treasurer.  Anna holds a CPA, CMA designation.

Rick Lancaster

Rick Lancaster

Director

Rick Lancaster is a retired financial services industry senior executive and former President and CEO of CIBC Life Insurance. Rick served on a not-for-profit board supporting Scouts Canada for 7 years. He was also former chair and director of the Canadian Association of Financial Institutions in Insurance.  Rick has his CPA-CGA designation, an MBA from the University of Toronto and an HBA from the Ivey School of Business, Western University.  Rick is a 6 year survivor of NHL.

Marie Lapointe

Marie Lapointe

Director

Marie Lapointe is a senior executive in the aluminum industry with strategic planning and business improvement experience and a background in engineering. She retired from Rio Tinto as finished products Executive Director, and has held director roles at Steel Mill and Alcan.  She was Business Woman of Year for the Richelieu Sorel-Tracy region in 2014 and the work chair of United Way.  She has been a member of several associations including the Foundation of CEGEP College in Sorel-Tracy.  Marie has a Bachelors in Engineering from the University of Chicoutimi.  Marie’s mother has Acute Lymphocytic Leukemia (ALL).  

Jennifer Marley

Jennifer Marley

Director

A proven marketing leader and strategic advisor with 30 years of experience, Jennifer Marley solves the highest-level, toughest strategic challenges for her clients at the marketing advisory firm, Sklar Wilton & Associates (SW&A). In her 18 years at SW&A, Jennifer has been honoured to act as strategic and insights advisor to some of Canada’s finest companies to collaboratively solve tough business challenges to unlock growth and build stronger brands.

Her vision has been a driving force behind many successful culture, engagement and coaching initiatives at SW&A leading the firm to be named as one of Canada’s Best Workplaces, as well as, an Employee Recommended Workplace in 2017 and 2018.

The blood cancer cause is a personal one for Jennifer. She is a 14-year leukemia survivor and is dedicated volunteer for The Leukemia & Lymphoma Society of Canada.  She is also a keen adventurer who enjoys new challenges including biking, hiking, trekking, and zip-lining in some of the most exotic and beautiful parts of the world.  She is a mother of two, Matt 22 and Kate 20, who she is helping transition through university to adulthood. Her husband Murray enjoys accompanying her on her adventures.

Gord McFarlane

Gord McFarlane

Director

Gord McFarlane is the Regional Director – Southern Alberta & Okanagan Valley for the CFO Centre, a provider of part time CFO’s globally.  He recently retired from Grant Thornton LLP after a 30 year career, where he was the Regional Managing Partner for Western Canada and a member of the firm’s National Management Committee. He was also the first National Managing Partner of the firm’s Advisory Services across Canada.  Gord is a FCA, FCPA and a Chartered Business Valuator.

Gord is the treasurer and a board member of the HomeSpace Society, a non-profit organization providing housing for Calgary’s homeless.  He is the past chair of the Calgary Philharmonic Orchestra and currently a trustee of the Calgary Philharmonic Orchestra Foundation.

Gord was diagnosed with Prolymphocytic Leukemia in 2015 and began treatment immediately, which included a successful stem cell transplant from his donor, his sister.  

Paul R. Meinema

Paul R. Meinema

Director

Paul Meinema is the National President of UFCW Canada — Paul is also Executive Vice President, UFCW International and a member of the UFCW International Executive Committee.

Paul Meinema’s dedication to UFCW spans four decades, going back to the early 1980s when he first volunteered to serve his co-workers as a shop steward while working at an Alberta meat processing plant.  In 1990, Paul was hired as a UFCW Canada local union representative, and later as a UFCW Canada International Representative. In 2002, Paul was elected as President of UFCW Canada Local 1400 — the largest private-sector union local in Saskatchewan.

In 2009, Paul Meinema moved from his Local 1400 presidency to join the UFCW Canada national leadership team as Executive Assistant to the National President. In 2013, Paul Meinema was elected UFCW Canada National President, and UFCW International Executive Vice President.

Kathleen Meriwether

Kathleen Meriwether

Director

Kathleen Meriwether is the Americas Leader of the Health Sciences team of Ernst & Young’s Fraud Investigation & Dispute Services practice.  Kathleen specializes in assisting health sciences companies with global risk and compliance assessments and regulatory compliance analyses.  Kathleen works closely with management teams, compliance officers and counsel to identify compliance and enforcement risks, determine potential vulnerabilities and recommend solutions from business and operational perspectives.  Kathleen also assists counsel, both outside and in-house, with fraud investigations (health care fraud and abuse, off label marketing, FCPA and other bribery and corruption), compliance inquiries and in strategizing responses to governmental subpoenas and other inquiries.  She has also worked on multiple projects assisting in-house counsel on management of significant litigation matters, from the cost management as well as investigative perspectives.

Prior to her tenure with EY, Kathleen was an Assistant United States Attorney in the U.S. Attorney’s Office for the Eastern District of Pennsylvania, focusing on health care fraud in the life sciences industry. 

Before becoming an AUSA, Kathleen spent over 16 years with Bristol-Myers Squibb Company in a number of legal, regulatory affairs and compliance positions, including as division counsel for the Oncology and Immunology franchise.  Kathleen’s industry experience includes such diverse areas as management of multi-district product liability and antitrust litigation, commercial litigation, labeling and promotional compliance, research and development, sales and marketing practices, including off-label marketing and fraud and abuse, government pricing and relationships with third parties, from contract research and sales organizations to licensors/ees and marketing partners.  Kathleen began her legal career as an associate with a national law firm based in Philadelphia.

Paul Petrelli

Paul Petrelli

Director

Paul Petrelli is a senior executive in the biotechnology/pharmaceutical industry with business leadership and marketing experience. He is currently the President of Biogen Canada and has held senior positions in the pharmaceutical industry. He is on the board of directors of several biotechnical organizations and is also on the volunteer board of the Oakville Hornets Hockey Association.  Paul has a B.Sc.in Genetics and Immunology from the University of Toronto.

Dr. Aaron D. Schimmer

Dr. Aaron D. Schimmer

Director

Aaron D. Schimmer, MD, PhD, FRCPC is a Staff Physician and Senior Scientist at the Princess Margaret Cancer Centre, University Health Network and Ontario Cancer Institute.  He is a member of the executive of the Ontario Cancer Institute and Dept. of Medical Oncology and Hematology at the Princess Margaret.  Dr. Schimmer holds the Baker Chair in Leukemia and Related Diseases at the University Health Network.  Dr. Schimmer is a Professor in the departments of Medicine and Medical Biophysics at the University of Toronto.  He is also the Past President and executive member of the Canadian Hematology Society. Dr. Schimmer is also a member of the LLSC Medical and Scientific Committee.

The Schimmer lab is focused in on developing new therapeutic strategies for leukemia with an interest in targeting unique mitochondrial and metabolic vulnerabilities in AML and AML stem cells.   He has advanced 3 drugs into clinical trial from his lab and has been the Principal Investigator on 9 additional clinical trials of novel agents for leukemia.  Dr. Schimmer is the author of over 200 publications and is an inventor on over 20 patent applications. He has received over 35 awards and honours for academic achievement including Member of the American Society of Clinical Investigation, Scholar in Clinical Research by the Leukemia and Lymphoma Society, and the Bernard and Francine Dorval young investigator award from the Canadian Cancer Society.